221 related articles for article (PubMed ID: 35114666)
1. Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose Witnesses.
McDonald R; Breidahl S; Abel-Ollo K; Akhtar S; Clausen T; Day E; Kelleher M; McAuley A; Petersen H; Sefranek M; Thiesen H; Strang J
Eur Addict Res; 2022; 28(3):220-225. PubMed ID: 35114666
[TBL] [Abstract][Full Text] [Related]
2. A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS.
Metrebian N; Carter B; Eide D; McDonald R; Neale J; Parkin S; Dascal T; Mackie C; Day E; Guterstam J; Horsburgh K; Kåberg M; Kelleher M; Smith J; Thiesen H; Strang J
BMC Public Health; 2023 Aug; 23(1):1608. PubMed ID: 37612698
[TBL] [Abstract][Full Text] [Related]
3. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
[TBL] [Abstract][Full Text] [Related]
4. Rethinking 'carriage' of take-home naloxone.
McDonald R; Parkin S; Eide D; Neale J; Clausen T; Metrebian N; Carter B; Strang J
Int J Drug Policy; 2021 Sep; 95():103253. PubMed ID: 33848942
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.
Sajwani HS; Williams AV
Harm Reduct J; 2022 Oct; 19(1):117. PubMed ID: 36266701
[TBL] [Abstract][Full Text] [Related]
6. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
McDonald R; Campbell ND; Strang J
Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
[TBL] [Abstract][Full Text] [Related]
7. Is a randomised controlled trial of take home naloxone distributed in emergency settings likely to be feasible and acceptable? Findings from a UK qualitative study exploring perspectives of people who use opioids and emergency services staff.
Sampson FC; Hughes J; Long J; Buykx P; Goodacre SW; Snooks H; Edwards A; Evans B; Jones J; Moore C; Johnston S
BMC Emerg Med; 2024 Apr; 24(1):75. PubMed ID: 38679713
[TBL] [Abstract][Full Text] [Related]
8. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
9. Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.
Holmén E; Warnqvist A; Kåberg M
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):24. PubMed ID: 37087485
[TBL] [Abstract][Full Text] [Related]
10. Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids.
Nielsen S; Peacock A; Lintzeris N; Bruno R; Larance B; Degenhardt L
Pain Med; 2018 Mar; 19(3):533-540. PubMed ID: 28340185
[TBL] [Abstract][Full Text] [Related]
11. Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm - An analysis informed by drug, set and setting.
Holmén E; Hammarberg A; Kåberg M; Storbjörk J
Int J Drug Policy; 2023 May; 115():104021. PubMed ID: 37011507
[TBL] [Abstract][Full Text] [Related]
12. Design details for overdose education and take-home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community.
Sellen K; Goso N; Halleran L; Mulvale-Fletcher A; Sarmiento F; Ligabue F; Handford C; Klaiman M; Milos G; Wright A; Charles M; Sniderman R; Hunt R; Parsons JA; Leece P; Hopkins S; Shahin R; Jüni P; Morrison L; Campbell DM; Strike C; Orkin A;
Health Expect; 2022 Oct; 25(5):2440-2452. PubMed ID: 35909312
[TBL] [Abstract][Full Text] [Related]
13. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
[TBL] [Abstract][Full Text] [Related]
14. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
[TBL] [Abstract][Full Text] [Related]
15. Who is using take-home naloxone? An examination of supersavers.
Eide D; Lobmaier P; Clausen T
Harm Reduct J; 2022 Jun; 19(1):65. PubMed ID: 35717240
[TBL] [Abstract][Full Text] [Related]
16. Proportion and conditions of use of intranasal take-home naloxone kits: A retrospective study in two French outpatient addiction centers, 2016-2020.
Chappuy M; Fezzani L; Ragonnet D; Berger-Vergiat A; Duvernay N; Lack P; Rolland B
Therapie; 2022; 77(5):581-584. PubMed ID: 35086690
[TBL] [Abstract][Full Text] [Related]
17. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
[TBL] [Abstract][Full Text] [Related]
18. [Take-home naloxone: a building block of drug emergency prophylaxis in Germany].
Fleißner S; Stöver H; Schäffer D
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Sep; 66(9):1035-1041. PubMed ID: 37233811
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data.
Lei V; Ferguson M; Geiger R; Williams S; Liu L; Buxton JA
Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):25. PubMed ID: 35361228
[TBL] [Abstract][Full Text] [Related]
20. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes.
Williams AV; Marsden J; Strang J
Addiction; 2014 Feb; 109(2):250-9. PubMed ID: 24103087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
